1. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. (8th May 2017) Authors: Bamias, A.; Gibbs, E.; Khoon Lee, C.; Davies, L.; Dimopoulos, M.; Zagouri, F.; Veillard, A.-S.; Kosse, J.; Santaballa, A.; Mirza, M. R.; Tabaro, G.; Vergote, I.; Bloemendal, H.; Lykka, M.; Floquet, A.; Gebski, V.; Pujade-Lauraine, E. Journal: Annals of oncology Issue: Volume 28:Number 8(2017) Page Start: 1842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA. (23rd June 2022) Authors: Zanwar, S.; Abeykoon, J.; Castillo, J.; Durot, E.; Kastritis, E.; Uppal, E.; Morel, P.; Tawfiq, R.; Montes, L.; Paludo, J.; Sarosiek, S.; Kumar, S.; Ogunbiyi, O.; Cornillet-Lefebvre, P.; Kyle, R.; Delmer, A.; Gertz, M.; Dimopoulos, M.; Ansell, S.; Treon, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM). (23rd June 2022) Authors: Dimopoulos, M.; Opat, S.; D'Sa, S.; Jurczak, W.; Lee, H.-P.; Cull, G.; Owen, R. G.; Marlton, P.; Wahlin, B. E.; Garcia-Sanz, R.; McCarthy, H.; Mulligan, S.; Tedeschi, A.; Castillo, J. J.; Czyz, J.; Fernandez De Larrea Rodriguez, C.; Belada, D.; Libby, E.; Matous, J.; Motta, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY. (23rd June 2022) Authors: Oriol, A.; Dimopoulos, M.; Schjesvold, F.; Beksac, M.; Yagci, M.; Larocca, A.; Guo, S.; Mu, Y.; Hong, K.; Dhanasiri, S.; Richardson, P.; Weisel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P926: DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND SEVERE RENAL IMPAIRMENT: RESULTS FROM THE PHASE 2 GMMG-DANTE TRIAL. (23rd June 2022) Authors: Leypoldt, L.; Gavriatopoulou, M.; Besemer, B.; Salwender, H.; Raab, M.-S.; Nogai, A.; Khandanpour, C.; Runde, V.; Zago, M.; Martus, P.; Goldschmidt, H.; Bokemeyer, C.; Dimopoulos, M.; Weisel, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PRELIMINARY CLINICAL DATA FROM A PHASE 1B STUDY OF MAVORIXAFOR AND IBRUTINIB IN PATIENTS WITH WALDENSTRöM MACROGLOBULINEMIA WITH MYD88 AND CXCR4 MUTATIONS. (17th June 2021) Authors: Treon, S.; Buske, C.; Thomas, S.; Branagan, A.; Dimopoulos, M.; Castillo, J. J.; Garzon, F.; Tang, W.; Ronan, R.; Seyffert, S.; Garg, V.; Ali, S.; Taveras, A.; Badarau, A.; Zmajkovicova, K.; Maier, S.; Maierhofer, B.; Matous, J. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT). (12th June 2019) Authors: Vassilakopoulos, T.P.; Papageorgiou, S.G.; Michail, M.; Angelopoulou, M.K.; Kourti, G.; Kalpadakis, C.; Kotsopoulou, M.; Leonidopoulou, T.; Konstantinidou, P.; Kotsianidis, I.; Boutsis, D.; Michali, E.; Sachanas, S.; Terpos, E.; Karianakis, G.; Poziopoulos, C.; Vadikolia, C.; Pigaditou, A.; Vraki... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗